This is a Validated Antibody Database (VAD) review about human PARP4, based on 9 published articles (read how Labome selects the articles), using PARP4 antibody in all methods. It is aimed to help Labome visitors find the most suited PARP4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PARP4 synonym: ADPRTL1; ARTD4; PARP-4; PARPL; PH5P; VAULT3; VPARP; VWA5C; p193

Absolute Antibody
mouse monoclonal (BG4)
  • immunocytochemistry; mouse; loading ...; fig 4c
Absolute Antibody PARP4 antibody (Absolute antibody, Ab00174-1.1) was used in immunocytochemistry on mouse samples (fig 4c). elife (2021) ncbi
mouse monoclonal (BG4)
  • immunohistochemistry; mouse; 1:333; loading ...
Absolute Antibody PARP4 antibody (Absolute antibody, Ab00174-1.1) was used in immunohistochemistry on mouse samples at 1:333. Nat Commun (2021) ncbi
Dako
mouse monoclonal (MOC-31)
  • immunohistochemistry - paraffin section; human; 1:25; tbl 1
In order to develop differential diagnoses for epithelioid mesothelioma with a solid growth pattern and poorly differentiated squamous cell carcinoma, Dako PARP4 antibody (Dako, MOC31) was used in immunohistochemistry - paraffin section on human samples at 1:25 (tbl 1). Histopathology (2017) ncbi
mouse monoclonal (MOC-31)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to compare the immunocytochemical utility of claudin-4 against those of Ber-EP4 and MOC-31 in effusion cytology, Dako PARP4 antibody (DAKO, MOC-31) was used in immunohistochemistry - paraffin section on human samples at 1:50. Diagn Cytopathol (2016) ncbi
mouse monoclonal (MOC-31)
  • immunohistochemistry - paraffin section; human; 1:200
In order to investigate the effect of neoadjuvant chemoradiotherapy on pancreatic adenocarcinoma cancer stem cell markers, Dako PARP4 antibody (Dako, M3525) was used in immunohistochemistry - paraffin section on human samples at 1:200. BMC Cancer (2014) ncbi
mouse monoclonal (MOC-31)
  • immunohistochemistry; human; 1:60
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, Dako PARP4 antibody (Dako, M3525) was used in immunohistochemistry on human samples at 1:60. PLoS ONE (2014) ncbi
mouse monoclonal (MOC-31)
  • immunohistochemistry; mouse; 1:35
Dako PARP4 antibody (DakoCytomation, MOC31) was used in immunohistochemistry on mouse samples at 1:35. PLoS ONE (2014) ncbi
International Blood Group Reference Laboratory
mouse monoclonal (BRIC 68)
  • flow cytometry; human; 5.7 ug/ml; fig s3a
International Blood Group Reference Laboratory PARP4 antibody (IBGRL Research Products, BRIC68) was used in flow cytometry on human samples at 5.7 ug/ml (fig s3a). Nat Commun (2017) ncbi
BD Biosciences
mouse monoclonal (hTNFR-RP-M12)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences PARP4 antibody (BD, 551503) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
Articles Reviewed
  1. Bossaert M, Pipier A, Riou J, Noirot C, Nguyên L, Serre R, et al. Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands. elife. 2021;10: pubmed publisher
  2. Hanna R, Flamier A, Barabino A, Bernier G. G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer's disease. Nat Commun. 2021;12:1828 pubmed publisher
  3. Trakarnsanga K, Griffiths R, Wilson M, Blair A, Satchwell T, Meinders M, et al. An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells. Nat Commun. 2017;8:14750 pubmed publisher
  4. Kushitani K, Amatya V, Okada Y, Katayama Y, Mawas A, Miyata Y, et al. Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma. Histopathology. 2017;70:375-384 pubmed publisher
  5. Oda T, Ogata S, Kawaguchi S, Minabe S, Dokyu M, Takahashi H, et al. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology. Diagn Cytopathol. 2016;44:499-504 pubmed publisher
  6. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  7. Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, et al. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer. 2014;14:687 pubmed publisher
  8. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed publisher
  9. Heidemann F, Schildt A, Schmid K, Bruns O, Riecken K, Jung C, et al. Selectins mediate small cell lung cancer systemic metastasis. PLoS ONE. 2014;9:e92327 pubmed publisher